[BLANK]
Comments (0)
Share

US regulators accept ‘chip in a pill’ application

Publication Title
The Financial Times Limited
Publication/Creation Date
September 10 2015
Creators/Contributors
Andrew Ward (creator)
Proteus Digital Health (contributor)
Food And Drug Administration (FDA) (contributor)
Media Type
Newspaper Article
Persuasive Intent
Information
Description
"Smart medicines that tell doctors when their patients have taken them moved a step closer to reality after a company developing the first “digital pill” had its drug application accepted by US regulators. The hope is that the pill, produced by Proteus Digital Health, will help ensure patients stick to their prescriptions and so reduce wasteful spending on drugs that are not taken properly." by Andrew Ward
HCI Platform
Ingestible
Discursive Type
Responses To Inventions
Location on Body
Digestive Tract
Augments
Healing, Treating, Regulating, Monitoring, Managing
Technology Keywords
Ingestible Sensors, Digital Pills, Smart Pills, Remote Monitoring, Remote Patient Monitoring
Keywords
Health, Medication, Mental Health, Medical, Patients, Compliance, Elderly, Ethics
Marketing Keywords
Proteus Digital Health, Otsuka Pharmaceutical
Related Objects
Dr. Kev Dhaliwal - PROTEUS Clinical Lead
Proteus Digital Health - Your Health, Powered By You
Otsuka and Proteus® Announce the First U.S. FDA Approval of a Digital Medicine System: Abilify MyCite® (aripiprazole tablets with sensor)
Related Items
Andrew Ward
Financial Times
Proteus Digital Health
Food And Drug Administration (FDA)
Date archived
March 15 2016
Last edited
July 21 2020
How to cite this entry
Andrew Ward. (September 10 2015). "US regulators accept ‘chip in a pill’ application". The Financial Times Limited. Financial Times. Fabric of Digital Life. https://fabricofdigitallife.com/index.php/Detail/objects/1535